Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» lung cancer
lung cancer
Closely Watched Mirati Reveals Results to Rival Amgen Drug
Closely Watched Mirati Reveals Results to Rival Amgen Drug
Bloomberg
Mirati Therapeutics
Amgen
adagrasib
lung cancer
Flag link:
Flame Biosciences to Ignite Pipeline with $100M Common Stock Financing
Flame Biosciences to Ignite Pipeline with $100M Common Stock Financing
BioSpace
Flame Biosciences
lung cancer
Flag link:
BridgeBio's Navire preps SHP2 blocker for lung cancer trial after positive mouse study
BridgeBio's Navire preps SHP2 blocker for lung cancer trial after positive mouse study
Fierce Biotech
Bridge Bio
Navire Pharma
lung cancer
clinical trials
IACS-13909
Flag link:
FDA starts quick review of Merck KGaA’s MET-targeting lung cancer drug
FDA starts quick review of Merck KGaA’s MET-targeting lung cancer drug
Pharmaforum
Merck KGaA
MET inhibitors
tepotinib
lung cancer
Flag link:
Teva Pharmaceuticals Unit Actavis Generics Wins FDA Approval for Lung Cancer Drug Pemetrexed
Teva Pharmaceuticals Unit Actavis Generics Wins FDA Approval for Lung Cancer Drug Pemetrexed
Motley Fool
generics
Teva Pharmaceutical
Actavis
lung cancer
Pemetrexed
chemotherapy
Alimta
Flag link:
AZ aims to cut cancer clinic visits with new Imfinzi regimen
AZ aims to cut cancer clinic visits with new Imfinzi regimen
Pharmaforum
AstraZeneca
lung cancer
bladder cancer
Imfinizi
dosing
Flag link:
Deaths from the most common lung cancer are falling fast, hinting at the impact of improved treatment
Deaths from the most common lung cancer are falling fast, hinting at the impact of improved treatment
Stat
lung cancer
non-small cell lung cancer
targeted therapeutics
Flag link:
Bristol Myers' Opdivo-Yervoy duo slashes mesothelioma death risk by 26%
Bristol Myers' Opdivo-Yervoy duo slashes mesothelioma death risk by 26%
Fierce Pharma
WCLC
lung cancer
mesothelioma
Bristol-Myers Squibb
Opdivo
Yervoy
clinical trials
Flag link:
Pfizer's Lorbrena makes play for earlier lung cancer use with Xalkori-topping data
Pfizer's Lorbrena makes play for earlier lung cancer use with Xalkori-topping data
Fierce Pharma
Pfizer
Lorbrena
lung cancer
Xalkori
clinical trials
Flag link:
A turn-up for Spectrum’s book
A turn-up for Spectrum’s book
EP Vantage
poziotinib
Spectrum Pharmaceuticals
lung cancer
Takeda
Flag link:
Lung cancer study IDs new 'epigenomic' target for diagnosis and treatment
Lung cancer study IDs new 'epigenomic' target for diagnosis and treatment
Fierce Biotech
Harvard
MIT
epigenomics
cancer
lung cancer
diagnostics
Flag link:
In pilot of patient-reported outcomes project, FDA hopes to encourage ‘more rigorous’ data collection
In pilot of patient-reported outcomes project, FDA hopes to encourage ‘more rigorous’ data collection
MedCity News
AstraZeneca
clinical trials
Tagrisso
FDA
lung cancer
patients
Flag link:
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Pharmaforum
Daiichi Sankyo
AstraZeneca
Enhertu
stomach cancer
colorectal cancer
lung cancer
ASCO 2020
Flag link:
AstraZeneca's Blockbuster Lung Cancer Drug Has a Huge Sales Boost Ahead
AstraZeneca's Blockbuster Lung Cancer Drug Has a Huge Sales Boost Ahead
Motley Fool
AstraZeneca
ASCO 2020
lung cancer
adjuvants
Tagrisso
Flag link:
AstraZeneca bid to expand lung cancer drug's use boosted by trial data
AstraZeneca bid to expand lung cancer drug's use boosted by trial data
BioPharma Dive
AstraZeneca
Tagrisso
lung cancer
clinical trials
ASCO 2020
Flag link:
3 Roche Companies Hope to Make Clinical Trials More Efficient
3 Roche Companies Hope to Make Clinical Trials More Efficient
Medical Devices and Diagnostics Industry
Flatiron Health
Foundation Medicine
Genentech
Roche
genomics
clinical trials
lung cancer
Flag link:
AstraZeneca to unveil key data for cancer drugs at ASCO
AstraZeneca to unveil key data for cancer drugs at ASCO
Pharmaforum
AstraZeneca
ASCO 2020
Tagrisso
lung cancer
Enhertu
breast cancer
gastric cancer
colorectal cancer
Flag link:
ASCO 2020 – first-line lung cancer focus
ASCO 2020 – first-line lung cancer focus
EP Vantage
Roche
Merck
Bristol-Myers Squibb
ASCO 2020
lung cancer
Keytruda
tiragolumab
Opdivo
Yervoy
Flag link:
Go or no go? Oncology dominates upcoming decisions
Go or no go? Oncology dominates upcoming decisions
EP Vantage
FDA
oncology
AstraZeneca
Lynparza
ovarian cancer
prostate cancer
Bristol-Myers Squibb
Opdivo
lung cancer
Flag link:
#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions
#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions
Endpoints
Novartis
Incyte
AACR
lung cancer
MET inhibitors
capmatinib
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »